In conclusion, the present study reports novel evidence that although GH treatment increases pro-BDNF in multiple brain regions associated with motor and cognitive function poststroke, the neurorestorative actions of BDNF and the role of mTOR in these actions appear to be brain region-specific and mostly confined to the peri-infarct area. The gene discussed is GH1; the disease is infarction.